The SCAPIS study – a way to find new therapies for heart and lung diseases

The Swedish CArdioPulmonarybioImage Study (SCAPIS) combines the use of new imaging technologies, advances in large-scale omics, Swedish registers, epidemiological analysis and wellness profiling. The information obtained will be used to combat cardiopulmonary diseases.

IVA Conference Center, Grev Turegatan 16, Stockholm
Thursday, April 7, 2016 16:45 - 18:45

Booking is closed

Booking is closed

The seminar will present the latest developments in the project and the potential for future research through collaboration with major Swedish research infrastructures.


Welcome Inger Andersson, Chairman of Division X Biotechnology Introduction Staffan Josephson, Division X Biotechnology SCAPIS – Sweden’s largest, most comprehensive study on cardiac and pulmonary diseases Professor Göran Bergström, Senior Consultant and Head of Physiology Group, Wallenberg Laboratory, University of Gothenburg

Merging large-scale population studies and registers – a unique competitive edge for Swedish research Professor Annika Rosengren, Sahlgrenska University Hospital Deep molecular profiling meets large-scale epidemiology to promote health Professor Mathias Uhlén, Science for Life Laboratory and AlbaNova University Center, KTH DHR wellness profiling project at FIMM (Institute for Molecular Medicine Finland): molecular health profiles during a lifestyle change Professor Olli Kallioniemi, MD, PhD, Director of the Science for Life Laboratory, Molecular Precision Medicine Karolinska Institutet

You can have an impact


By sharing this seminar information with your network you will help us raise awareness about these important social issues.


By participating in seminars we can improve our knowledge together about these important social issues.